Director, Head and Neck Radiation Oncology Cancer Research
University of Colorado Denver School of Medicine
Head and Neck Steering Committee Member, RTOG
Head of Radiation Oncology GU subcommittee member, SWOG
Dr. David Raben is a board certified radiation oncologist at the University of Colorado. Residency training in radiation oncology was conducted at the John Hopkins Hospital (1991-1994). Presently, he is a full professor and scientist in the only NCI-designated Comprehensive Cancer Center in the Rocky Mountain region at the University of Colorado Denver. Dr. Raben is nationally recognized regarding his work in targeted therapies and radiation, primarily in GI, head and neck cancer and lung cancer. He serves on the head and neck steering committee of the National Cancer Institute sponsored radiation cooperative group (RTOG). In addition, he is a the Head of Radiation Oncology Subcommittee of the GU section of the SWOG and has extensive experience with both low dose (LDR) and high dose rate (HDR) brachytherapy. The UCD Radiation Oncology Dept. was the only site approved by the RTOG in Colorado to participate in the national phase II HDR brachytherapy trial. In addition, Dr Raben was the first radiation oncologist in the Rocky Mountain region to implement accelerated intensity modulated radiation to the prostate and pelvis, recently published in a peer-reviewed journal. His focus has also been on blocking critical growth, invasion and angiogenic signaling pathways driving cancer cells to enhance radiation therapy. He is an ad hoc reviewer for Cancer Research, Clinical Cancer Research, Head and Neck, Journal of Clinical Oncology and the International Journal of Radiation Oncology, Biology and Physics. He serves as the Director of the Radiological Sciences Core at the Cancer Center. Dr. Raben has contributed to 80 publications.